Current status and prospects of metal-organic frameworks (MOFs) in drug delivery for women's health.
文献摘要
Women's health includes many biological and social challenges, such as reproductive disorders, maternal complications, osteoporosis, and gynecological cancers. Many current treatments have limitations like poor drug solubility, side effects, and lack of targeted delivery for female physiology. Metal-organic frameworks (MOFs), crystalline porous materials made of metal nodes and organic linkers, are being studied as advanced drug delivery systems to solve these problems. This review explains how MOF-based systems can be used in women's healthcare. MOFs like UiO-66 and ZIF-8 are used in targeted chemotherapy for breast and ovarian cancers. These systems are pH-responsive and ligand-functionalized, which improves treatment efficiency and reduces side effects. MOFs are also useful in bone health, where they deliver calcium, vitamin D 3 , and other osteogenic ions for treating postmenopausal osteoporosis. MOFs are being explored for hormonal regulation, non-hormonal contraception, and treatment of gynecological infections. However, there are still challenges such as long-term safety, metal ion leakage, and the need for proper testing in maternal-fetal conditions. With further research on safe synthesis methods and toxicity evaluation, MOFs can become an important platform for personalized and effective treatments in women's health.